Association of hyperglycemia and markers of hepatic dysfunction with dextrose infusion rates in Korean patients receiving total parenteral nutrition

American Journal of Health-System Pharmacy

Volumn 60, Issue 17, 2003, Pages 1760-1766

  Kim, Hyunah ^a   Son, Eunsun ^b   Kim, Jungtae ^c   Choi, Kyungeob ^d   Kim, Choongbae ^b   Shin, Wangyoon ^e   Suh, Okkyung ^e  

^a Yonsei University Medical Center ^*

^b Yonsei University College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

^d Samsung Medical Center   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Caloric agents; Dextrose; Drug administration rate; Hyperglycemia; Injections; Liver failure; Nutrition; Toxicity

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; GLUCOSE; INFUSION FLUID; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN;

ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFUSION RATE; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION; BLOOD; COMPARATIVE STUDY; DRUG ADMINISTRATION; ENZYMOLOGY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER DISEASE; MALE; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; TIME;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE; HUMANS; HYPERGLYCEMIA; INFUSIONS, INTRAVENOUS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; PARENTERAL NUTRITION, TOTAL; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 1542783230     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.17.1760     Document Type: Article

References (23)

1. Rombeau JL, Calewell MD. Clinical nutrition: parenteral nutrition. 2nd Ed. Philadelphia: W. B. Saunders; 1993:367-81.
2. Dudrick SJ, MacFadyen BV Jr, Van Buren CT et al. Parenteral hyperalimentation. Metabolic problems and solutions. Ann Surg. 1972; 176:259-64.
3. Goins WA, Wiles CE III, Cerra FB. Pharmacology, monitoring, and nutritional support. Crit Care Clin. 1993; 9:689-713.
4. Brenner WI, Lansky Z, Engelman RM et al. Hyperosmolar coma in surgical patients: an iatrogenic disease of increasing incidence. Ann Surg. 1973; 178:651-4.
5. Rossini AA. Why control blood glucose levels? Arch Surg. 1976; 111:229-33.
6. Bower RH. Nutrition and immune function. Nutr Clin Pract. 1990; 5:189-95.
7. Hennessey PJ, Black CT, Andrassy RJ. Nonenzymatic glycosylation of immunoglobulin G impairs complement fixation. J Parenter Enteral Nutr. 1991; 15:60-4.
8. MacRury SM, Gemmell CG, Paterson KR et al. Changes in phagocytic function with glycaemic control in diabetic patients. J Clin Pathol. 1989; 42:1143-7.
9. Fisher RL. Hepatobiliary abnormalities associated with total parenteral nutrition. Gastroenterol Clin North Am. 1989; 18:645-66.
10. Grant JP, Cox CE, Kleinman LM et al. Serum hepatic enzyme and bilirubin deviations during parenteral nutrition. Surg Gynecol Obstet. 1977; 145:573-80.
11. Greenlaw CW. Liver enzyme elevations associated with TPN day. Drug Intell Clin Pharm. 1980; 14:702-9.
12. Clarke PJ, Ball MJ, Kettlewell MG. Liver function tests in patients receiving parenteral nutrition. J Parenter Enteral Nutr. 1991; 15:54-9.
13. Luman W, Shaffer JL. Prevalence, outcome and associated factors of deranged liver function tests in patients in home parenteral nutrition. Clin Nutr. 2002; 21:337-43.
14. Cavicchi M, Beau P, Crenn P et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000; 132:525-32.
15. Freund HR. Abnormalities of liver function and hepatic damage associated with total parenteral nutrition. Nutrition. 1991; 7:1-5.
16. Wolfe RR, O'Donnell TF Jr, Stone MD et al. Investigation of factors determining the optimal glucose infusion rate in total parenteral nutrition. Metabolism. 1980; 29:892-900.
17. Guidelines for the use of parenteral and enteral nutrition in adults and pediatric patients. J Parenter Enteral Nutr. 2002; 26 (suppl 1):1SA-138SA.
18. Bjerke HS, Shabot MM. Glucose intolerance in critically ill surgical patients: relationship to total parenteral nutrition and severity of illness. Am Surg. 1992; 58:728-31.
19. Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract. 1996; 11:151-6.
20. Lynch M, Gammage MD, Lamb P et al. Acute myocardial infarction in diabetic patients in the thrombolytic era. Diabetes Med. 1994; 11:162-5.
21. Leor J, Goldbourt U, Reicher-Reiss H et al. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. Am J Med. 1993; 94:265-73.
22. Meguid MM, Schimmel E, Johnson WC et al. Reduced metabolic complications in total parenteral nutrition: pilot study using fat to replace one-third of glucose calories. J Parenter Enteral Nutr. 1982; 6:304-7.
23. Meguid MM, Akahoshi MP, Jeffers S et al. Amelioration of metabolic complications of conventional total parenteral nutrition. A prospective randomized study. Arch Surg. 1984; 119:1294-8.